Antivirals Could Reduce Long COVID Risk and H...

In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ...  Show more

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ...  Show more

There’s a ton of hoopla over these new coronavirus vaccines. But given that they’ve been produced at warp speed — can we trust them? We also find out what’s going on with “long haulers.” How common is it to be sick for months from Covid-19? Plus, fresh new science about why some ...  Show more

Can people who are vaccinated still carry and transmit the coronavirus to other people? How effective are the vaccines against coronavirus variants? And what's the deal with side effects? In this episode, an excerpt of Maddie's appearance on another NPR podcast, It's Been a Minut ...  Show more

In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical appraisal masters: Dr. Andrew Morris, Dr. Rohit Mohindra and Dr. Justin Morgenstern. What is the evidence for the neutralizing monoclonal antibody medications ...  Show more

Does your immunity still last for months? We asked a researcher who has been studying omicron reinfections. This episode was produced by Jon Ehrens, edited by Matthew Collette, fact-checked by Laura Bullard, engineered by Paul Mounsey, and hosted by Sean Rameswaram. Transcript at ...  Show more